drugset / Trial / NCT03233295

A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency

NCT03233295

Phase 4 Completed 108 enrolled Kwang Dong Pharmaceutical co., ltd.
NaSingle-groupOpen-labelTreatment

Summary

A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in adults with Vitamin D Deficiency

Timeline

Start
2014-10-23
Primary completion
2016-08-27
Completion
2016-08-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 200000 iu Intramuscular

Indications